Belluscura plc

Equities

BELL

GB00BD3B8Z11

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. Other stock markets 11:35:00 2024-07-12 am EDT			5-day change	1st Jan Change
14.5 ^GBX	0.00%		-3.33%	-36.96%

Jul. 11	Jonathan Satchell to Step Down from His Role as a Non-Executive Director of Belluscura plc	CI
Jul. 03	Belluscura Raises GBP2 Million via Conditional Issue of Loan Notes, Share Subscription	MT

Jonathan Satchell to Step Down from His Role as a Non-Executive Director of Belluscura plc

July 11, 2024 at 06:30 am EDT

Belluscura plc announced that Jonathan Satchell, Non-executive Director, has informed the Board that he intends to step down from his role as a Non-executive Director with effect from 11 July 2024. Jonathan was appointed to the Board in February 2024 following the acquisition of TMT Acquisition plc by the Company.

Latest news about Belluscura plc

Jonathan Satchell to Step Down from His Role as a Non-Executive Director of Belluscura plc	Jul. 11	CI
Belluscura Raises GBP2 Million via Conditional Issue of Loan Notes, Share Subscription	Jul. 02	MT
Creo extends contract; Belluscura raises funds	Jul. 02	AN
Belluscura plc announced that it has received £1.71 million in funding	Jul. 01	CI
EARNINGS: Blue Star loss narrows; Heavitree Brewery profit down	Jun. 27	AN
Belluscura plc Reports Earnings Results for the Full Year Ended December 31, 2023	Jun. 27	CI
Belluscura Raises New Funds via New Investor Subscription	Jun. 24	MT
Belluscura sees "significant" interest in planned loan note placing	Jun. 24	AN
EARNINGS AND TRADING: Distil loss widens; Genflow welcomes grant	Jun. 12	AN
Belluscura plc announced that it expects to receive £2.4 million in funding	Jun. 11	CI
AIM WINNERS & LOSERS: Zenova scores NHS deal; Staffline "encouraged"	May. 22	AN
Belluscura sees financial hit from delay to closing TMT acquisition	Apr. 02	AN
AIM WINNERS & LOSERS: 88 Energy finds oil at Hickory-1; Redx to delist	Apr. 02	AN
Belluscura plc Provides Earnings Guidance for the Full Year 2024	Apr. 02	CI
Belluscura Amasses 98% Stake in TMT Acquisition	Mar. 11	MT
Belluscura plc completed the acquisition of TMT Acquisition Plc.	Mar. 07	CI
TMT Acquisition Delists from London Bourse	Mar. 07	MT
Belluscura to Launch Mandatory Acquisition of Remaining TMT Shares	Feb. 19	MT
FTSE 100 Closes Lower as Equities Slid on U.S. Inflation Data	Feb. 13	DJ
Belluscura Enters Oxygen Concentrator Distribution Deal With US-based Sunset Healthcare	Feb. 13	MT
Belluscura plc Announces Implementation of Distribution Agreement with Sunset Healthcare Solutions	Feb. 13	CI
FTSE 100 Closes Down 0.3% Dragged by Miners, Financial Stocks	Feb. 09	DJ
Belluscura Declares TMT Acquisition Offer Unconditional	Feb. 09	MT
AIM WINNERS & LOSERS: Belluscura shares up as wraps up TMT takeover	Feb. 09	AN
Belluscura rises as TMT Acquisition takeover offer becomes unconditional	Feb. 09	AN

Chart Belluscura plc

Duration

Period

More charts

Company Profile

Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The Company's product X-PLOR, is a modular portable oxygen concentrator. The X-PLOR is lightweight, specifically designed to replace metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLOR can deliver up to 95% pure oxygen to patients 24 hours a day, seven days a week. The Company is focused on developing medical devices who suffer from chronic lung diseases, such as the Chronic Obstructive Pulmonary Disease (COPD), respiratory distress caused by COVID-19, and many other respiratory disorders. It is also focused on developing, licensing and manufacturing portable oxygen concentrators for use in treating lung diseases with its oxygen platform technologies, to include recreational and industrial oxygen concentrators, wound care devices, drug delivery devices and more.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-09-01 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Belluscura plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.1883 USD

Average target price

0.4474 USD

Spread / Average Target

+137.52%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
BELLUSCURA PLC	-36.96%	31.54M
ABBOTT LABORATORIES	-5.31%	181B
MEDTRONIC PLC	-5.38%	100B
BECTON, DICKINSON AND COMPANY	-6.04%	65.01B
HOYA CORPORATION	+16.45%	45.75B
DEXCOM, INC.	-8.08%	44.8B
CENCORA, INC.	+8.38%	43.72B
METTLER-TOLEDO INTERNATIONAL, INC.	+12.06%	29.01B
TERUMO CORPORATION	+17.98%	26.03B
WEST PHARMACEUTICAL SERVICES, INC.	-8.28%	24.28B

Other Medical Equipment, Supplies & Distribution